🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine the relationship between genomic ...
Status
Completed
Location
Northwestern Memorial Hospital
Start Date
2007-07
Trial ID
NCT00857844
The study will evaluate the pharmacokinetics (PK) of AZD6793 when administe...
Status
Completed
Location
Research Site
Start Date
2024-07-23
Trial ID
NCT06494644
Treatments Being Tested
Phase II multicenter, Canadian only study - open to 25 subjects. Study open...
Status
Unknown
Location
Hospital Maissoneuve
Start Date
2016-03
Trial ID
NCT02519816
This is a Phase 1 study evaluating the safety of ABT-263 administered in co...
Status
Completed
Location
University of Arizona Cancer Center - North Campus /ID# 16721
Start Date
2009-07-21
Trial ID
NCT00788684
The purpose of this study is to evaluate the safety, tolerability and pharm...
Status
Completed
Location
Site US0006
Start Date
2014-10-14
Trial ID
NCT02175433
Treatments Being Tested
The goal of this clinical trial is to evaluate the feasibility of remote ti...
Status
Completed
Location
Applied Health Sciences Building - University of Illinois at Chicago
Start Date
2023-10-18
Trial ID
NCT06022887
Rhinitis is a type of upper respiratory infection with a common nasal patho...
Status
Completed
Location
Thai Binh University of Medicine and Pharmacy
Start Date
2022-09-26
Trial ID
NCT05984004
Treatments Being Tested
The purpose of this study is to evaluate the safety, pharmacokinetics (PK),...
Status
Completed
Location
Research Facility
Start Date
2004-08
Trial ID
NCT00097747
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as idarubicin and cytarabine, w...
Status
Completed
Location
AZ Sint-Jan
Start Date
2003-11
Trial ID
NCT00077116
Evaluate the proportion of patients with an urticaria control test \[UCT\] ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2015-04-22
Trial ID
NCT02550106
Treatments Being Tested